FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Vanta Bioscience IPO.
April 2, 2024 7:17:00 PM
The company will not receive any of the proceeds of the IPO, which will go to ULSE, a nonprofit arm of the Underwriters Laboratories group, the filings show. Norges Bank Investment Management ...
Published by : Chicago TribuneApril 2, 2024 1:15:00 PM
Private equity firm Silver Lake is acquiring all outstanding shares, stockholders will receive $27.50 per share, and will value the owner of WME at $13 billion. By Erik Hayden Executive Editor ...
Published by : The Hollywood ReporterApril 5, 2024 10:30:00 AM
Contineum Therapeutics has lowered its IPO expectations as the Johnson & Johnson-partnered biotech prepares to make the jump to the public markets this morning Friday, April 5. The San Diego-based ...
Published by : FierceBiotechMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechApril 2, 2024 1:34:00 PM
It's the latest venture capital-backed company to pursue its Wall Street dreams as the IPO market thaws. Should the company�s IPO be successful, it would join San Francisco-based social media ...
Published by : The Business JournalsApril 2, 2024 3:30:00 AM
UL Solutions filed for an initial public offering (IPO) Tuesday, aiming to raise up to $812 million. UL Solutions, which provides safety-focused testing, inspection, and certification services ...
Published by : InvestopediaApril 11, 2024 8:36:00 AM
The Reddit IPO will arguably go down as one of the most anticipated initial public offerings (IPOs) of 2024, and it did not disappoint. On Wednesday, March 20, the social media company priced its ...
Published by : KiplingerApril 3, 2024 3:29:00 AM
The financial loss comes days after reports of Bithumb facing potential internal issues that led to the delay of its planned IPO. Bitkub targets to go public on the Stock Exchange of Thailand in ...
Published by : CoinTelegraphMarch 27, 2024 4:04:00 PM
However, IPO volumes were flat on the same period last year and less than half the levels seen in early 2022, with $22.4 billion raised in the first quarter so far. With interest rate cuts ...
Published by : ReutersApril 10, 2024 11:30:00 AM
The Japanese owner of 7-Eleven, Seven & i Holdings, is considering listing its superstore business as part of efforts to focus on its convenience-store segment. The company, which also owns other ...
Published by : Wall Street JournalApril 2, 2024 3:30:00 AM
Following quickly on the heels of debuts from Reddit and Astera Labs, the choice by Rubrik to pursue a public offering now could indicate that the IPO market is warming for tech companies.
Published by : Yahoo FinanceVanta Bioscience IPO Listing Date
› Listing Date: Friday, October 6, 2017
› BSE Script Code: 540729
› Listing In: ‘M’ Group of Securities
› ISIN: INE695X01011
› Issue Price: Rs 50 Per Equity Share
› Face Value: Rs 10 Per Equity Share
The issue of Vanta Bioscience Ltd opens on Sep 25, 2017 and closes for subscription on Sep 27, 2017. The equity shares of the company to be list at BSE SME. The price band for the issue has been fixed at Rs 50.
Vanta Bioscience Ltd is entering in the capital market with an IPO of 1,512,000 Equity Shares of Rs 10 aggregating up to Rs 7.56 Cr. The price band for the issue has been fixed at Rs 50.
Vanta Bioscience Ltd (VBL) is a preclinical contract research company whhich offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
The issue opens on Sep 25, 2017 and closes for subscription on Sep 27, 2017. The equity shares of the company to be list at BSE SME platform.
The Vanta Bioscience IPO is proposed to open on September 25, 2017. The IPO application ends on September 27, 2017.
Retail investors can apply in the retail or non-institutional investor category from September 25, 2017 to September 27, 2017. The Vanta Bioscience IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Vanta Bioscience IPO will open for subscription on September 25, 2017. The public issue will close on September 27, 2017.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|